Primary carcinoid tumour of the prostate

Zarkovic, Andrea; Masters, Jonathan; Carpenter, Logan

doi:10.1080/14767050500058903

Cited by 10 publications

(2 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…One case based on the illustration provided is a urethral carcinoid as opposed to prostatic in origin. 42 The reports by Tash and colleagues of a 38-year-old man and by Slater and colleagues of a 69-year-old individual may be carcinoids, yet IHC stains for PSA or any other prostatic marker were not reported. 43,44 Similarly, in the study by Wasserstein et al, 45 no IHC analyses were performed.…”

Section: Carcinoid Tumormentioning

confidence: 99%

Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation

Epstein

Amin

Beltran

et al. 2014

American Journal of Surgical Pathology

462

489

View full text Add to dashboard Cite

On July 31, 2013, the Prostate Cancer Foundation assembled a working committee on the molecular biology and pathologic classification of neuroendocrine differentiation in prostate cancer. The committee consisted of genitourinary oncologists, urologists, urological surgical pathologists, basic scientists, and translational researchers, with expertise in this field. It was concluded that the proceedings of the meeting should be reported in 2 manuscripts appealing to different target audiences, one to focus on surgical pathology and the other to review the molecular aspects of this disease. New clinical and molecular data emerging from prostate cancers treated by contemporary androgen deprivation therapies, as well as primary lesions, have highlighted the need for refinement of diagnostic terminology to encompass the full spectrum of neuroendocrine differentiation. It is envisioned that specific criteria associated with the refined diagnostic terminology will lead to clinically relevant pathologic diagnoses that will stimulate further clinical and molecular investigation and identification of appropriate targeted therapies.

show abstract

Section: Carcinoid Tumormentioning

confidence: 99%

Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation

Epstein

Amin

Beltran

et al. 2014

American Journal of Surgical Pathology

462

489

View full text Add to dashboard Cite

show abstract

“…Lacking a specific classification, neuroendocrine tumors of the prostate are usually reported as carcinoid tumors, which are low-grade neuroendocrine carcinomas, and high-grade neuroendocrine carcinoma, which encompasses large neuroendocrine, small cell neuroendocrine carcinoma, and combined tumors, based on their histological and immunophenotypical profile [2–7]. …”

Section: Introductionmentioning

confidence: 99%

Review of Small Cell Carcinomas of the Prostate

et al. 2011

View full text Add to dashboard Cite

Small cell carcinoma of the prostate is a rare neoplasm, with only a few series hitherto reported. A little less than half of the cases are associated with conventional acinar adenocarcinoma, which are usually high grade. Although consensus has not been reached, the majority of patients with small cell neuroendocrine carcinoma of the prostate have advanced disease at diagnosis and disproportionally low PSA levels compared to patients with conventional acinar adenocarcinoma. Treatment consists mainly of chemotherapy associated with surgery. Radiation therapy is reserved for selected cases. This study reviews the most up-to-date information on small cell carcinomas of the prostate.

show abstract

Unusual Epithelial and Nonepithelial Neoplasms of the Prostate

Osunkoya

Magi‐Galluzzi

2015

Genitourinary Pathology

View full text Add to dashboard Cite

Primary carcinoid tumour of the prostate

Cited by 10 publications

References 9 publications

Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation

Proposed Morphologic Classification of Prostate Cancer With Neuroendocrine Differentiation

Review of Small Cell Carcinomas of the Prostate

Unusual Epithelial and Nonepithelial Neoplasms of the Prostate

Contact Info

Product

Resources

About